Successful treatment of gastroparesis following total esophagectomy using botulinum toxin.
Tcherniak
A
A
Department of Gastroenterology, Kaplan Medical Center, Rehovot, Israel.
Kashtan
D H
DH
Melzer
E
E
D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000627:therapeutic use*; D004938:Esophageal Neoplasms / Q000601:surgery; D016629:Esophagectomy / Q000009:adverse effects*; D005500:Follow-Up Studies; D018589:Gastroparesis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D011708:Pylorus
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A